[1]
C. Sköld, N. P. Hailer, and H. Mallmin, “Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial”, ActaO, vol. 97, pp. 217–224, Apr. 2026.